New Stellest lenses offer an FDA-approved option to help manage childhood nearsightedness The U.S. Food and Drug Administration (FDA) has authorized marketing of the Essilor Stellest eyeglass lenses—the first spectacle lenses in the United States approved to slow the progression of myopia in children ages 6–12. The decision marks an important milestone for families seeking […]
FDA authorizes first eyeglass lenses to slow progression of pediatric myopia



